GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Chengdu Huasun Technology Group Inc Ltd (SZSE:000790) » Definitions » Return-on-Tangible-Equity

Chengdu Huasun Technology Group (SZSE:000790) Return-on-Tangible-Equity : 1.17% (As of Mar. 2024)


View and export this data going back to 1998. Start your Free Trial

What is Chengdu Huasun Technology Group Return-on-Tangible-Equity?

Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Chengdu Huasun Technology Group's annualized net income for the quarter that ended in Mar. 2024 was ¥9.1 Mil. Chengdu Huasun Technology Group's average shareholder tangible equity for the quarter that ended in Mar. 2024 was ¥779.1 Mil. Therefore, Chengdu Huasun Technology Group's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2024 was 1.17%.

The historical rank and industry rank for Chengdu Huasun Technology Group's Return-on-Tangible-Equity or its related term are showing as below:

SZSE:000790' s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -6.66   Med: 5.46   Max: 23.67
Current: 3.41

During the past 13 years, Chengdu Huasun Technology Group's highest Return-on-Tangible-Equity was 23.67%. The lowest was -6.66%. And the median was 5.46%.

SZSE:000790's Return-on-Tangible-Equity is ranked worse than
57.49% of 934 companies
in the Drug Manufacturers industry
Industry Median: 6.265 vs SZSE:000790: 3.41

Chengdu Huasun Technology Group Return-on-Tangible-Equity Historical Data

The historical data trend for Chengdu Huasun Technology Group's Return-on-Tangible-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chengdu Huasun Technology Group Return-on-Tangible-Equity Chart

Chengdu Huasun Technology Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Return-on-Tangible-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.34 4.27 6.20 4.72 3.40

Chengdu Huasun Technology Group Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Return-on-Tangible-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.57 5.83 3.20 3.40 1.17

Competitive Comparison of Chengdu Huasun Technology Group's Return-on-Tangible-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, Chengdu Huasun Technology Group's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Chengdu Huasun Technology Group's Return-on-Tangible-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Chengdu Huasun Technology Group's Return-on-Tangible-Equity distribution charts can be found below:

* The bar in red indicates where Chengdu Huasun Technology Group's Return-on-Tangible-Equity falls into.



Chengdu Huasun Technology Group Return-on-Tangible-Equity Calculation

Chengdu Huasun Technology Group's annualized Return-on-Tangible-Equity for the fiscal year that ended in Dec. 2023 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets )/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=27.659/( (847.941+776.971 )/ 2 )
=27.659/812.456
=3.40 %

Chengdu Huasun Technology Group's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2024 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(Q: Mar. 2024 )  (Q: Dec. 2023 )(Q: Mar. 2024 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets)/ count )
(Q: Mar. 2024 )  (Q: Dec. 2023 )(Q: Mar. 2024 )
=9.12/( (776.971+781.134)/ 2 )
=9.12/779.0525
=1.17 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Mar. 2024) net income data. Return-on-Tangible-Equity is displayed in the 10-year financial page.


Chengdu Huasun Technology Group  (SZSE:000790) Return-on-Tangible-Equity Explanation

Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.


Be Aware

Net Income is used.

Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.


Chengdu Huasun Technology Group Return-on-Tangible-Equity Related Terms

Thank you for viewing the detailed overview of Chengdu Huasun Technology Group's Return-on-Tangible-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Chengdu Huasun Technology Group (SZSE:000790) Business Description

Traded in Other Exchanges
N/A
Address
1168 Fuxin Avenue, High-tech Zone (West District), No. 101, 1st Floor, Building 2, Sichuan, Chengdu, CHN, 611731
Chengdu Huasun Technology Group Inc Ltd, formerly Chengdu Taihe Health Technology Group Inc Ltd is engaged in the production and distribution of traditional Chinese medicines and chemical drugs in China. It is also involved in veterinary drugs, biological vaccines, and modern steel products.
Executives
Huang Xue Director
Wang Ren Guo Directors, executives
Ye Jing Executives
Jiang Li Executives
Bo Jian Ping Executives
Wang Tian Xiang Executives
Tang Ji Ying Executives
Li Jian Hua Executives
Wan Fang Executives
Wei Yi Guo Executives
Chen Zhong Qiao Director

Chengdu Huasun Technology Group (SZSE:000790) Headlines

No Headlines